Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the following 3 stocks made the list for top value stocks in the Pharmaceuticals ...

Between family game nights, pickleball with friends and walking Fido, the last thing we want is to be sidelined by joint pain ...

Viatris Inc. ( VTRS) Evercore 8th Annual Healthcare Conference December 3, 2025 8:45 AM EST ...

Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

Researchers compared survival outcomes in patients with stage III colon cancer randomized to receive either celecoxib or placebo for 3 years with chemo.

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

The drug tested was Rybelsus, a pill approved only for type 2 diabetes. Like Novo's blockbusters Ozempic and Wegovy, it contains semaglutide.

Learn the ideal timing to take adaptogens like ashwagandha, rhodiola, and ginseng to support stress relief, boost energy, and promote natural sleep.

With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...

To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...